| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
| |
|
|
| Abstract Details |
 |
|
| |
| |
| |
|
|
| |
A simple method to measure antibody affinity against the hepatitis B surface antigen using a routine quantitative system |
|
|
|
|
| |
Liu H, Han Y, Wang B. J Virol Methods. 2011 Feb 21. [Epub ahead of print] |
|
| |
|
|
| |
Abstract
The aim of the study was to establish a simple method to measure antibody affinity to hepatitis B surface antigen (anti-HBs) by using a routine quantitative system to explore the significance of anti-HBs affinity. Serum samples of hepatitis B patients who had been discharged from the hospital were collected at the time of re-examination. The 60 patients with resolved HBV infection were divided into two groups based on the serological markers measured in the samples: an anti-HBs group (anti-HBs-only positive) and an anti-HBs positive with anti-HBc group. The serum samples were diluted prior to the measurement of total anti-HBs by using a commercial assay with the AxSYM device. The total anti-HBs (mIU/mL) of all dilutions were measured, and the positive data (>10mIU/mL) were transformed into logarithmic values (lgU). The relative affinity of anti-HBs was calculated and derived from the mass action formula. The absolute value of (lgU(1) - lgU(2)) positively correlated with the antibody affinity. The results indicated that affinity of anti-HBs in the samples obtained from the anti-HBs-alone positive group was statistically higher than that of the other group (P<0.05), though no significant difference was noted in regard to the total antibody activity (P>0.05). This simple approach to measurement of anti-HBs antibody affinity may serve as a new tool in clinical laboratories and contribute to the management of patients with hepatitis B.
|
|
|
|
| |
| |
|